Skip to main content

Bank of New York Mellon Corp

Bank

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1390777 NEW YORK, NY

Position in INBX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,739,508
-$373,584 QoQ
Shares Held
25,874
-3.3% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 79.90646981525856.ToString("F0")% Shared 0.ToString("F0")% None 20.09353018474144.ToString("F0")%

Common Shares in INBX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,649,111 across 269 Biotechnology names. INBX ranks #139 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INBX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,739,508 25,874
2025-12-31 $2,113,092 26,748
2025-09-30 $1,688,209 50,125
2025-06-30 $720,319 50,478
2025-03-31 $738,670 52,800
2024-12-31 $792,253 51,445
2024-09-30 $402,977 25,733
2024-06-30 $443,888 31,326